Stay updated on Pediatric Tolerability of Xerecept in Clinical Trial

Sign up to get notified when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Tolerability of Xerecept in Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    An addition of Revision: v3.4.2 is displayed. The notice about government funding lapse and the reference to Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:20:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a government funding lapse notice banner and updated the site revision to v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:28:05.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A glossary toggle was added and footer notes were updated to include No FEAR Act Data and Revision: v3.4.0, with minor wording changes (e.g., capitalization in 'Last Update Submitted that Met QC Criteria'). The study content remains unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T06:20:24.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no study content or page functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:17:57.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    A consolidated Locations section now lists Illinois and Massachusetts as study sites, replacing separate 'Illinois Locations' and 'Massachusetts Locations' entries. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T20:32:32.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:26:28.000Z thumbnail image

Stay in the know with updates to Pediatric Tolerability of Xerecept in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.